ECSP034872A - Nuevos heterociclos 3 - Google Patents

Nuevos heterociclos 3

Info

Publication number
ECSP034872A
ECSP034872A EC2003004872A ECSP034872A ECSP034872A EC SP034872 A ECSP034872 A EC SP034872A EC 2003004872 A EC2003004872 A EC 2003004872A EC SP034872 A ECSP034872 A EC SP034872A EC SP034872 A ECSP034872 A EC SP034872A
Authority
EC
Ecuador
Prior art keywords
heterociclos
new
imidazotriacinones
prophylaxis
medicaments
Prior art date
Application number
EC2003004872A
Other languages
English (en)
Inventor
Hilmar Bischoff
Heike Gielen-Haertwig
Karl Heinz Schlemmer
Mary F Fitzgerald
Graham Sturton
Ulrich Niewohner
Alija Cristina Alonso
Martin Hendrix
Maria T Niewohner
Dagmar Schauss
Nils Burkhardt
Volker Geiss
Nigel J Cuthbert
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of ECSP034872A publication Critical patent/ECSP034872A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a 7-(4-terc butil-ciclohexil)-imidazotriacinonas, a procedimientos para su preparación y a su uso en medicamentos, especialmente para el tratamiento y/o profilaxis de procesos inflamatorios y/o enfermedades inmunitarias.
EC2003004872A 2001-06-01 2003-12-01 Nuevos heterociclos 3 ECSP034872A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113344.6A GB0113344D0 (en) 2001-06-01 2001-06-01 Novel heterocycles 3

Publications (1)

Publication Number Publication Date
ECSP034872A true ECSP034872A (es) 2004-01-28

Family

ID=9915717

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004872A ECSP034872A (es) 2001-06-01 2003-12-01 Nuevos heterociclos 3

Country Status (28)

Country Link
US (2) US7115602B2 (es)
EP (1) EP1399447A1 (es)
JP (1) JP2004536078A (es)
KR (1) KR20040023605A (es)
CN (1) CN1512993A (es)
BG (1) BG108381A (es)
BR (1) BR0210910A (es)
CA (1) CA2449095A1 (es)
CO (1) CO5540381A2 (es)
CZ (1) CZ295609B6 (es)
EC (1) ECSP034872A (es)
EE (1) EE200300570A (es)
GB (1) GB0113344D0 (es)
GT (1) GT200200099A (es)
HR (1) HRP20031090A2 (es)
HU (1) HUP0400773A3 (es)
MX (1) MXPA03010985A (es)
NO (1) NO20035324D0 (es)
NZ (1) NZ529848A (es)
PE (1) PE20030231A1 (es)
PL (1) PL366906A1 (es)
RU (1) RU2003138078A (es)
SK (1) SK14672003A3 (es)
SV (1) SV2003001061A (es)
UA (1) UA75149C2 (es)
UY (1) UY27312A1 (es)
WO (1) WO2002098879A1 (es)
ZA (1) ZA200309111B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2388111A (en) * 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
GB2388594A (en) * 2002-05-16 2003-11-19 Bayer Ag Imidazo-triazine PDE 4 inhibitors
FR2850653A1 (fr) * 2003-02-04 2004-08-06 Univ Pasteur Derives de pyrazolotriazine, procede de preparation et utilisations
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体
AR058071A1 (es) * 2005-10-03 2008-01-23 Astrazeneca Ab Derivados de dihidropirazolo (3,4-e)(1,4)diazepina. procesos de obtencion y composiciones farmaceuticas.
WO2012123406A1 (en) 2011-03-17 2012-09-20 Algiax Pharmaceuticals Gmbh Novel use of imidazotriazinones
WO2013156231A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of imidazotriazinones in neuropathic pain
CA2942446A1 (en) * 2014-03-28 2015-10-01 Algiax Pharmaceuticals Gmbh Treatment of cognitive disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
AU738675B2 (en) * 1997-11-12 2001-09-20 Bayer Intellectual Property Gmbh 2-phenyl-substituted imidazotriazinones as phosphodiesterase inhibitors
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
US6503908B1 (en) * 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds

Also Published As

Publication number Publication date
US20050065153A1 (en) 2005-03-24
HUP0400773A3 (en) 2007-09-28
CZ20033275A3 (en) 2004-03-17
CZ295609B6 (cs) 2005-08-17
NZ529848A (en) 2006-02-24
BG108381A (bg) 2004-11-30
PE20030231A1 (es) 2003-05-16
BR0210910A (pt) 2004-06-08
NO20035324L (no) 2003-11-28
ZA200309111B (en) 2004-11-24
NO20035324D0 (no) 2003-11-28
EE200300570A (et) 2004-04-15
JP2004536078A (ja) 2004-12-02
UY27312A1 (es) 2003-02-28
SV2003001061A (es) 2003-03-18
EP1399447A1 (en) 2004-03-24
PL366906A1 (en) 2005-02-07
US20030139415A1 (en) 2003-07-24
HRP20031090A2 (en) 2005-08-31
CO5540381A2 (es) 2005-07-29
MXPA03010985A (es) 2004-10-28
GT200200099A (es) 2003-02-13
RU2003138078A (ru) 2005-05-27
UA75149C2 (en) 2006-03-15
GB0113344D0 (en) 2001-07-25
US7115602B2 (en) 2006-10-03
CA2449095A1 (en) 2002-12-12
KR20040023605A (ko) 2004-03-18
WO2002098879A1 (en) 2002-12-12
CN1512993A (zh) 2004-07-14
SK14672003A3 (sk) 2004-08-03
HUP0400773A2 (hu) 2004-07-28

Similar Documents

Publication Publication Date Title
DOP2002000429A (es) Imidazotriazinas
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
ATE448232T1 (de) Substituierte heterozyklen
AR037109A1 (es) Uso de flibanserina
UY27720A1 (es) Aroilpiridinonas monocíclicas,
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
TW200510343A (en) Substituted dihydroquinazolines
UY28313A1 (es) Nonadepsipeptidos acilados
UY28080A1 (es) Isómeros posicionales del ifn peg alfa 2a
UY29189A1 (es) Nonadepsipeptidos acilados ii
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
ECSP034872A (es) Nuevos heterociclos 3
UY28542A1 (es) Amidas macrocíclicas antibacterianas
ATE455789T1 (de) Substituierte nonadepsipeptide
UY27733A1 (es) Derivados de ciclopenteno.
DOP2002000404A (es) Nuevos heterocuclos 3.
UY26945A1 (es) Alcanosulfonatos de fenoxifenilo
HRP20050790A2 (en) New combinations and new use of selected pharmaceutically active compounds
HN2002000129A (es) Nuevos heterociclos 3
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
UY26930A1 (es) Amidas de ácido fenilciclohexanocarboxílico sustituido y su uso
MXPA04006120A (es) Piperidin-2,6-dionas sustitudas heterociclicamente en posicion 3.
MD2053B1 (en) Remedy with interferon inducing action